Single answer
Is Adlai Nortye Ltd (ANL) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Adlai Nortye Ltd is $16.00, which is $6.29 (64.78%) above the current price today's price.
Low target: $16.00 | High target: $16.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Adlai Nortye Ltd a clinicalstage biotechnology company engages in the research and development of pharmaceutical products Its lead product is AN2025 a panphosphoinositide 3kinase inhibitor which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas The company is also developing AN0025 a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent nonsmall cell lung cancer and urothelial cancer after antiPD1PDL1 treatments recurrent triplenegative breast cancer microsatellite stable colorectal cancer and cervical cancer after standard of care treatments and AN4005 an oral smallmolecule PDL1 inhibitor which is in Phase I clinical trials to induce and stabilize PDL1 dimerization and disrupt the interaction between PD1 and PDL1 Its preclinical candidates include AN8025 a multifunctional antibody as T cell and antigenpresenting cell modulator and AN9025 an oral small molecule panKRAS inhibitor The company was founded in 2004 and is based in Grand Cayman the Cayman Islands
Website: https://www.adlainortye.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.38. Cash flow to debt ratio: -1.90. Net profit margin: 0.00%. Inflation risk score: high (0.75/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Adlai Nortye Ltd is $3M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Adlai Nortye Ltd 10 years ago, but if you had invested on 2023-09-28 when the price was $0.0000, you would have made a profit of $9.71 per share or 97,099,900.00%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.